Clinical Trial News and Research

RSS

Understanding of tumor biology opens new opportunities to conduct clinical trial for thoracic tumors

Our understanding of tumor biology has improved and continues to expand at a rapid pace, and this has opened new opportunities for cancer clinical trials, particularly for thoracic tumors. The identification and molecular alterations in the cancer and the possibility to specifically and selectively target them, has dramatically improved the treatment efficacy in patients with lung cancer.

24 Jun 2015

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

The NHS is under immense pressure not only to continue to deliver improved care but also to change how it is delivering care to meet rising and changing demand with an essentially fixed amount of money and resources - all at the same time. Patience and persistence with good humour are thus vital characteristics to have.

23 Jun 2015

New breath test could help diagnose oesophageal and gastric cancer in minutes

Researchers have devised a breath test that can help doctors diagnose the early signs of oesophageal and gastric cancer in minutes.

23 Jun 2015

UT System's clinical trials network can help get more effective drugs to patients faster

The University of Texas System has launched a groundbreaking clinical trials network to ensure drugs and therapies developed by researchers at UT institutions get to patients faster and are effective.

23 Jun 2015

Atrial fibrillation patients who stop blood thinners before elective surgery have less risk of major bleeding

Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patients who were given a "bridge" therapy, according to research led by Duke Medicine.

23 Jun 2015

PSMA can be an ideal target for diagnosis and treatment of prostate cancer

Prostate-specific membrane antigen (PSMA) is a surface protein that is normally present on healthy prostate cells, but is found at much higher levels on prostate cancer cells. It is barely found in the rest of the body. "Therefore, PSMA is an ideal target for diagnostic purposes as well as targeted therapies against prostate cancer," says biotechnologist Dr. Matthias Eder of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).

23 Jun 2015

Findings could help improve patient care, reduce cancer screening costs around the world

A large clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa has found that contrary to expectations, a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained blood clots in their legs and lungs.

23 Jun 2015

VG Life Sciences receives U.S. patent for combination cancer therapy

VG Life Sciences, Inc., a biotechnology company developing therapies for cancer, autoimmune and infectious diseases, announced that the U.S. Patent and Trademark Office will issue Patent No. 9073985 covering VGLS' combination therapy for treating drug-resistant cancer by combining an autophagy inhibitor with a chemotherapy drug.

22 Jun 2015

Planning for first clinical trial of MERS-CoV vaccine candidate now underway

Researchers from Ludwig-Maximilians-Universitaet in Munich have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the coronavirus that causes Middle East Respiratory Syndrome. Planning for the first clinical trial is now underway.

22 Jun 2015

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.

19 Jun 2015

Mayo Clinic, TGen researchers help launch national clinical trial to treat advanced skin cancer patients

Mayo Clinic and the Translational Genomics Research Institute are helping launch a national clinical trial that will apply the latest in precision medicine to treat advanced melanoma skin cancer.

19 Jun 2015

$Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC$

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Amgen today announced that a Phase 3 study evaluating Vectibix (panitumumab) and best supportive care (BSC) met its primary endpoint, demonstrating a statistically significant improvement in overall survival (OS) in patients with chemorefractory wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC) compared to those patients treated with BSC alone.

19 Jun 2015

Scientists reveal new combination method that efficiently destroys cancer cells

Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.

18 Jun 2015

Many people with type 2 diabetes also suffer from hypoglycaemia

Researchers from the University of Leicester and Leicester's Hospitals have discovered that many people suffering from type 2 diabetes also suffer from low blood sugar levels that can pose a significant risk to their health.

18 Jun 2015

New study launched in Liberia to better understand health consequences of Ebola virus disease

The Liberia-U.S. clinical research partnership known as PREVAIL has launched a study of people in Liberia who have survived Ebola virus disease (EVD) within the past two years. The study investigators hope to better understand the long-term health consequences of EVD, determine if survivors develop immunity that will protect them from future Ebola infection, and assess whether previously EVD-infected individuals can transmit infection to close contacts and sexual partners.

18 Jun 2015

ExCellThera's stem cell expansion approach may benefit AML patients undergoing transplants

Patients suffering from acute myeloid leukemia, who require stem cell transplantation as part of their treatment,may now benefit from a new best-in-class process that improves the viability and success of cord blood stem cell transplantation.

18 Jun 2015

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Eli Lilly and Company and Sarah Cannon Research Institute today announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway.

17 Jun 2015

FDA accepts BiondVax's IND for Multimeric-001 vaccine

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced that its Investigational New Drug Application (IND) for its Multimeric-001 vaccine (M-001), has been accepted by the US Food and Drug Administration, and the Company was notified by its regulatory advisors that the 'study may proceed'.

17 Jun 2015

New form of talking therapy shows promise for people suffering from chronic low back pain

New research from Royal Holloway, University of London has found that a new form of talking therapy is a credible and promising treatment for people with chronic low back pain who are also suffering from related psychological stress.

17 Jun 2015

Loyola tests new combination treatment for people living with cancer that has spread to spine

Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.

17 Jun 2015

Clinical Trial News and Research

Understanding of tumor biology opens new opportunities to conduct clinical trial for thoracic tumors

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

New breath test could help diagnose oesophageal and gastric cancer in minutes

UT System's clinical trials network can help get more effective drugs to patients faster

Atrial fibrillation patients who stop blood thinners before elective surgery have less risk of major bleeding

PSMA can be an ideal target for diagnosis and treatment of prostate cancer

Findings could help improve patient care, reduce cancer screening costs around the world

VG Life Sciences receives U.S. patent for combination cancer therapy

Planning for first clinical trial of MERS-CoV vaccine candidate now underway

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

Mayo Clinic, TGen researchers help launch national clinical trial to treat advanced skin cancer patients

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Scientists reveal new combination method that efficiently destroys cancer cells

Many people with type 2 diabetes also suffer from hypoglycaemia

New study launched in Liberia to better understand health consequences of Ebola virus disease

ExCellThera's stem cell expansion approach may benefit AML patients undergoing transplants

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

FDA accepts BiondVax's IND for Multimeric-001 vaccine

New form of talking therapy shows promise for people suffering from chronic low back pain

Loyola tests new combination treatment for people living with cancer that has spread to spine

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer